肠道微生物群生态拓作为癌症免疫治疗的下一代生物标志物
1State Key Laboratory of Systems Medicine for Cancer, NHC Key Laboratory of Digestive Diseases, Division of Gastroenterology and Hepatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, Shanghai Cancer Institute, Shanghai 200001, China.
Cell
|June 21, 2024
概括
研究人员使用生态拓来预测癌症免疫疗法的新型肠道微生物生物标志物. 这种方法克服了先前研究的局限性,提供了一种更可靠的方法来识别可能对治疗有反应的患者.
科学领域:
- 微生物组研究
- 癌症免疫疗法
- 生物标志物的发现
背景情况:
- 肠道微生物组是癌症免疫疗法的有希望的生物标志物.
- 研究异质性限制了肠道微生物组生物标志物的临床应用.
- 预测免疫治疗反应仍然是瘤学中的一个重大挑战.
研究的目的:
- 开发一个可靠的生物标志物来预测癌症免疫疗法的有效性.
- 解决肠道微生物组生物标记研究中的异质性问题.
- 用生态原则进行微生物社区分析.
主要方法:
- 对肠道微生物群的组成和结构进行分析.
- 将生态拓原理应用于微生物数据.
- 用于预测免疫治疗反应的生物标志物的验证.
主要成果:
- 基于肠道微生物群生态拓的新生物标志物被确定.
- 这种生物标志物有效预测免疫疗法的有效性.
- 这种方法比以前的方法更可靠.
结论:
- 肠道微生物群的生态拓为癌症免疫治疗提供了强大的预测生物标志物.
- 这一发现有助于个性化癌症治疗策略.
- 进一步的研究可以在临床环境中完善和实施这种生物标志物.
相关概念视频
01:27Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K